Testing CBD for alcohol cravings
Part of Mental health clinical trials.
This study tests whether a medication called cannabidiol (CBD) can help reduce cravings for alcohol. Over several weeks, you will take the study pill and attend lab sessions where you can choose to drink alcohol in a safe setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with alcohol use disorder
- You drink above a certain amount each week (more than 10 drinks for women, 15 for men)
- You are willing to stop using cannabis and all other drugs during the study
- You have not had seizures or severe withdrawal from alcohol in the past
- You are not currently being treated for alcohol use disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether cannabidiol (CBD) can help people cut down or quit drinking alcohol. It enrolls adults diagnosed with alcohol use disorder and wanting to reduce drinking, while checking for safety and other mental health or drug use factors.
This study tests whether cannabidiol (CBD), a compound from cannabis, can help people who drink alcohol regularly reduce their drinking or change their drinking patterns. You may be eligible if you're 21-65, have used CBD or cannabis before, drink alcohol regularly, and don't take certain medications that could interfere.
This trial tests if taking a ketone supplement can reduce alcohol cravings and drinking in people with mild to moderate alcohol use disorder who are not currently seeking treatment. You will have MRI scans, PET scans, and supervised drinking sessions to see how the supplement affects your brain and alcohol intake.
This early-phase study looks at how alcohol affects impulsivity (tendency to act quickly) and people’s subjective experiences. You may be able to join if you drink regularly and meet the study safety rules.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.